Sue Desmond-Hellmann says it's time for her to leave the Gates Foundation. Strategy chief Mark Suzman will now take the helm
Susan Desmond-Hellmann, the longtime researcher and executive who helped lead Genentech to develop the first gene-targeted cancer therapies, is stepping down after 5 years as CEO of the Bill & Melinda Gates Foundation.
“Stepping down as CEO of@GatesFoundation is, without a doubt, the toughest decision of my career,” she wrote in the first of a series of tweets announcing and reflecting on her departure. “But one of my mantras is ‘take your own pulse first.’ Over the last few months, I’ve done just that and concluded that I need to slow down.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.